From April 1993 to March 1994, 187 ischemic stroke patients were prospectively registered in the Hospital de Santa Maria Stroke Data Base. Demographic features, vascular risk factors, clinical symptoms and signs, computerized tomography results, the most plausible stroke mechanism, and the vascular territories affected were compared between patients with and without nausea or vomiting by univariate and multivariate statistical techniques. The same comparisons were performed in the subgroups of patients with stroke in the vertebrobasilar or carotid territory. This regression model was validated in a second sample of 102 ischemic stroke patients registered in the data base from August 1995 to April 1996. Twenty-two percent of 187 patients with ischemic stroke complained of nausea or vomiting within a 12-hour interval of stroke onset. Nausea or vomiting was more frequent in vertebrobasilar territory strokes (45%) than in carotid territory strokes (10%). In multiple regression analysis, vertebrobasilar stroke (odds ratio, OR, 3.6), headache (OR 3.1) and vertigo (OR 3.4) were significant independent predictors, while in the subgroup of patients with vertebrobasilar stroke, headache (OR 3.0) and vertigo (OR 2.5) were significant independent predictors. The identification of independent variables associated with nausea or vomiting in ischemic stroke allows the detection of patients at high risk of vomiting during the acute stroke phase and to postulate its possible pathophysiological mechanism, namely, stimulation of the vomiting center by vestibular or trigeminovascular afferents.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.